Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-24-000482

Chief Executive Officer gave up 10,796 shares (to pay taxes)

  • Chief Executive Officer acquired 31,198 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Robinson Chandler · Chief Executive Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-31 Exercise or conversion : show line 1 in the form +24,474 152,900.8 D
2023-12-31 Shares withheld for taxes : show line 2 in the form −8,469 $0.34 $2,881 144,431.8 D
2024-01-01 Exercise or conversion : show line 3 in the form +6,724 151,155.8 D
2024-01-01 Shares withheld for taxes : show line 4 in the form −2,327 $0.34 $792 148,828.8 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-12-31 Exercise or conversion : show line 5 in the form Restricted Stock Units −24,474 229,009 D
2024-01-01 Exercise or conversion : show line 6 in the form Restricted Stock Units −6,724 222,285 D
Loading xslF345X05/rdgdoc.xml…